MED-OLMESARTAN 20 MG
OLMESARTAN MEDOXOMIL : 20 MG · DIN 02442515 · GENERIC MEDICAL PARTNERS INC
Health Canada status: APPROVED
What is MED-OLMESARTAN?
MED-OLMESARTAN 20 MG contains OLMESARTAN MEDOXOMIL : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02442515, held by GENERIC MEDICAL PARTNERS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 01-May-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02442515 |
|---|---|
| Brand name | MED-OLMESARTAN |
| Generic / active ingredient | OLMESARTAN MEDOXOMIL : 20 MG |
| Manufacturer | GENERIC MEDICAL PARTNERS INC |
| Strength | 20 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09CA08 OLMESARTAN MEDOXOMIL |
| AHFS class | 24:32.08 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 01-May-2017 |
Is OLMESARTAN MEDOXOMIL in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C09CA08 OLMESARTAN MEDOXOMIL. 22 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-OLMESARTAN | 20 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02456311 |
| ACH-OLMESARTAN | 40 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02456338 |
| AURO-OLMESARTAN | 20 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02443864 |
| AURO-OLMESARTAN | 40 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02443872 |
| GLN-OLMESARTAN | 20 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02469812 |
| GLN-OLMESARTAN | 40 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02469820 |
| JAMP OLMESARTAN | 20 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02461641 |
| JAMP OLMESARTAN | 40 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02461668 |
| NRA-OLMESARTAN | 20 MG | TABLET | NORA PHARMA INC | MARKETED | DIN 02499258 |
| NRA-OLMESARTAN | 40 MG | TABLET | NORA PHARMA INC | MARKETED | DIN 02499266 |
Who else supplies OLMESARTAN MEDOXOMIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OLMESARTAN MEDOXOMIL appears in 707 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.